A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study

Stevenson, 1998, Recognition and management of patients with heart failure, 310

Rich, 1988, Effect of DRGs on three-month readmission rate of geriatric patients with heart failure, Am J Pub Health, 78, 680, 10.2105/AJPH.78.6.680

Vinson, 1990, Early readmission of elderly patients with heart failure, J Am Geriatr Soc, 38, 1290, 10.1111/j.1532-5415.1990.tb03450.x

Adams, 1998, Post-hoc subgroup analysis and the truth of a clinical trial, Am Heart J, 136, 751, 10.1016/S0002-8703(98)70116-4

Nagagawa, 1995, Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy, J Clin Invest, 96, 1280

Yoshimura, 1993, Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure, Circulation, 87, 464, 10.1161/01.CIR.87.2.464

Wallen, 1997, Brain natriuretic peptide predicts mortality in the elderly, Heart, 77, 264, 10.1136/hrt.77.3.264

Daggubati, 1997, Adrenomedullin, endothelin, neuropeptide Y, atrial, brain and C-natriuretic prohormone peptides compared as early heart failure indicators, Cardiovasc Res, 36, 246, 10.1016/S0008-6363(97)00164-8

Richards, 1998, Plasma n-terminal probrain natriuretic peptide and adrenomedullin, Circulation, 77, 1921, 10.1161/01.CIR.97.19.1921

Murdoch, 1997, Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay, Heart, 78, 594, 10.1136/hrt.78.6.594

Mann, 1999, Mechanisms and models of heart failure, Circulation, 100, 999, 10.1161/01.CIR.100.9.999

Grantham, 1997, BNP, Circulation, 96, 388

Francis, 1990, Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure, Circulation, 82, 1724, 10.1161/01.CIR.82.5.1724

Remes, 1991, Neuroendocrine activity in untreated heart failure, Br Heart J, 65, 249, 10.1136/hrt.65.5.249

Swedberg, 1990, Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality, Circulation, 82, 1730, 10.1161/01.CIR.82.5.1730

Tsutamoto, 1995, Prognostic value of plasma intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure, Am J Cardiol, 76, 803, 10.1016/S0002-9149(99)80231-8

1991, Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction and congestive heart failure, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501

Bristow, 1996, Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure, Circulation, 94, 2807, 10.1161/01.CIR.94.11.2807

Murdoch, 1997, Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay, Heart, 78, 594, 10.1136/hrt.78.6.594

Klinge, 1998, An experimental study of cardiac natriuretic peptides as markers of development of CHF, Scand J Clin Lab Invest, 58, 683, 10.1080/00365519850186120

Grantham, 1997, BNP, Am J Physiol, 92, R1077

Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure: 46th Annual Scientific Session of the American College of Cardiology. Am J Physiol 1998;274:H1684–9.

Maeda K, Tsutamoto T, Wada A, et al. High level of plasma BNP at discharge is an independent risk factor for mortality and morbidity in patients with congestive heart failure (abstr). J Am Coll Cardiol 1999;33 Suppl A:192A.

Nagaya, 1998, Plasma brain natriuretic peptide is a marker for the prediction of progressive ventricular remodeling after acute myocardial infarction, Am Heart J, 135, 21, 10.1016/S0002-8703(98)70338-2

Stein, 1998, Natriuretic peptides, Am Heart J, 135, 914, 10.1016/S0002-8703(98)70054-7

Cheung, 1998, Natriuretic peptides—relevance in cardiac disease, J Am Med Assoc, 280, 1983, 10.1001/jama.280.23.1983

Tsutamoto, 1997, Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure, Circulation, 96, 509, 10.1161/01.CIR.96.2.509

1995, ACC/AHA task force report, Circulation, 92, 276

Koon, 2000, A rapid bedside test for brain natriuretic peptide accurately predicts cardiac function in patients referred for echocardiography, J Invest Med, 48, 56A

Sandberg SM, Chen HH, Stevens TL, et al. Superiority of brain natriuretic peptide in assessing efficacy of therapy to improve symptoms of congestive heart failure in the outpatient setting (abstr). J Am Coll Cardiol 1999;193A:1140–15.

Porter, 1989, Cloning of cDNA encoding porcine brain natriuretic peptide, J Biol Chem, 264, 6689, 10.1016/S0021-9258(18)83482-2

Sudoh, 1989, Cloning and sequence analysis of cDNA encoding—a precursor for human brain natriuretic peptide, Biochem Biophy Res Commun, 159, 1427, 10.1016/0006-291X(89)92269-9

Cheung, 1998, Natriuretic peptides—relevance in cardiovascular disease, J Am Med Assoc, 289, 1983, 10.1001/jama.280.23.1983

Hama, 1995, Rapid ventricular activation of brain natriuretic peptide gene expression in experimental acute myocardial infarction, Circulation, 92, 1558, 10.1161/01.CIR.92.6.1558

Poole-Wilson, 1999, Tailored treatment for heart failure, Am Heart J, 138, 1005, 10.1016/S0002-8703(99)70059-1

Richardson, 1999, Neurohumoral predictors of benefit from carvedilol in ischemic left ventricular dysfunction, Circulation, 99, 786, 10.1161/01.CIR.99.6.786

Murdoch, 1999, Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration, Am Heart J, 138, 1126, 10.1016/S0002-8703(99)70079-7